Taylor Frigon Capital Management LLC Myriad Genetics Inc Transaction History

Taylor Frigon Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 24, 2020	SELL	$9.78 - $29.53 $496,286 - $1.5 Million	-50,745 Closed	0 $0
Q4 2019 Jan 24, 2020	BUY	$20.93 - $35.1 $55,087 - $92,383	2,632 Added 5.47%	50,745 $1.38 Million
Q3 2019 Nov 01, 2019	BUY	$22.08 - $47.08 $48,796 - $104,046	2,210 Added 4.81%	48,113 $1.38 Million
Q2 2019 Jul 17, 2019	BUY	$22.67 - $35.0 $129,627 - $200,130	5,718 Added 14.23%	45,903 $1.28 Million
Q1 2019 Apr 25, 2019	SELL	$26.93 - $34.7 $6,490 - $8,362	-241 Reduced 0.6%	40,185 $1.33 Million
Q4 2018 Feb 07, 2019	BUY	$27.23 - $45.56 $13,533 - $22,643	497 Added 1.24%	40,426 $1.18 Million
Q3 2018 Oct 15, 2018	SELL	$37.57 - $50.34 $260,247 - $348,705	-6,927 Reduced 14.78%	39,929 $1.84 Million
Q2 2018 Aug 01, 2018	SELL	$27.75 - $40.17 $3,690 - $5,342	-133 Reduced 0.28%	46,856 $1.75 Million
Q1 2018 Apr 23, 2018	BUY	$28.83 - $41.01 $92,601 - $131,724	3,212 Added 7.34%	46,989 $1.39 Million
Q4 2017 Jan 25, 2018	BUY	$28.45 - $37.14 $1.25 Million - $1.63 Million	43,777	43,777 $1.5 Million

254

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.11B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Taylor Frigon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Taylor Frigon Capital Management LLC with notifications on news.